269 related articles for article (PubMed ID: 10526283)
1. Reversed CD4/CD8 ratios of tumor-infiltrating lymphocytes are correlated with the progression of human cervical carcinoma.
Sheu BC; Hsu SM; Ho HN; Lin RH; Torng PL; Huang SC
Cancer; 1999 Oct; 86(8):1537-43. PubMed ID: 10526283
[TBL] [Abstract][Full Text] [Related]
2. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of tumor-infiltrating lymphocytes in neoplastic progression and lymph node metastasis of human breast cancer.
Sheu BC; Kuo WH; Chen RJ; Huang SC; Chang KJ; Chow SN
Breast; 2008 Dec; 17(6):604-10. PubMed ID: 18656354
[TBL] [Abstract][Full Text] [Related]
4. A reversed CD4/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4(+)FOXP3(+) regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix.
Shah W; Yan X; Jing L; Zhou Y; Chen H; Wang Y
Cell Mol Immunol; 2011 Jan; 8(1):59-66. PubMed ID: 21200385
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of CD25 expression on the surface of activated tumor-infiltrating lymphocytes in human cervical carcinoma.
Sheu BC; Lin RH; Ho HN; Huang SC
Hum Immunol; 1997; 56(1-2):39-48. PubMed ID: 9455492
[TBL] [Abstract][Full Text] [Related]
6. Nodal metastasis in cervical cancer occurs in clearly delineated fields of immune suppression in the pelvic lymph catchment area.
Heeren AM; de Boer E; Bleeker MC; Musters RJ; Buist MR; Kenter GG; de Gruijl TD; Jordanova ES
Oncotarget; 2015 Oct; 6(32):32484-93. PubMed ID: 26431490
[TBL] [Abstract][Full Text] [Related]
7. Tumor-infiltrating CD4+ T lymphocytes in early breast cancer reflect lymph node involvement.
Macchetti AH; Marana HR; Silva JS; de Andrade JM; Ribeiro-Silva A; Bighetti S
Clinics (Sao Paulo); 2006 Jun; 61(3):203-8. PubMed ID: 16832552
[TBL] [Abstract][Full Text] [Related]
8. Tumor-infiltrating CD8+ and FOXP3+ lymphocytes before and after neoadjuvant chemotherapy in cervical cancer.
Liang Y; Lü W; Zhang X; Lü B
Diagn Pathol; 2018 Nov; 13(1):93. PubMed ID: 30474571
[TBL] [Abstract][Full Text] [Related]
9. Regulatory T Cells Suppress Natural Killer Cell Immunity in Patients With Human Cervical Carcinoma.
Chang WC; Li CH; Chu LH; Huang PS; Sheu BC; Huang SC
Int J Gynecol Cancer; 2016 Jan; 26(1):156-62. PubMed ID: 26512789
[TBL] [Abstract][Full Text] [Related]
10. CD8+ T lymphocytes are recruited to neoplastic cervix.
Bell MC; Edwards RP; Partridge EE; Kuykendall K; Conner W; Gore H; Turbat-Herrara E; Crowley-Nowick PA
J Clin Immunol; 1995 May; 15(3):130-6. PubMed ID: 7559915
[TBL] [Abstract][Full Text] [Related]
11. The number of tumor infiltrating T-cell subsets in lymph nodes from patients with Hodgkin lymphoma is associated with the outcome after first line ABVD therapy.
Alonso-Álvarez S; Vidriales MB; Caballero MD; Blanco O; Puig N; Martin A; Peñarrubia MJ; Zato E; Galende J; Bárez A; Alcoceba M; Orfão A; González M; García-Sanz R
Leuk Lymphoma; 2017 May; 58(5):1144-1152. PubMed ID: 27733075
[TBL] [Abstract][Full Text] [Related]
12. Immunophenotyping of patients with oral squamous cell carcinoma in peripheral blood and associated tumor tissue.
Grimm M; Feyen O; Hofmann H; Teriete P; Biegner T; Munz A; Reinert S
Tumour Biol; 2016 Mar; 37(3):3807-16. PubMed ID: 26474587
[TBL] [Abstract][Full Text] [Related]
13. CD8+ tumor-infiltrating lymphocytes together with CD4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma.
Fukunaga A; Miyamoto M; Cho Y; Murakami S; Kawarada Y; Oshikiri T; Kato K; Kurokawa T; Suzuoki M; Nakakubo Y; Hiraoka K; Itoh T; Morikawa T; Okushiba S; Kondo S; Katoh H
Pancreas; 2004 Jan; 28(1):e26-31. PubMed ID: 14707745
[TBL] [Abstract][Full Text] [Related]
14. Expression of inhibitory natural killer receptors on tumor-infiltrating CD8+ T lymphocyte lineage in human endometrial carcinoma.
Chang WC; Huang SC; Torng PL; Chang DY; Hsu WC; Chiou SH; Chow SN; Sheu BC
Int J Gynecol Cancer; 2005; 15(6):1073-80. PubMed ID: 16343184
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of immune cell infiltration within gallbladder cancer.
Nakakubo Y; Miyamoto M; Cho Y; Hida Y; Oshikiri T; Suzuoki M; Hiraoka K; Itoh T; Kondo S; Katoh H
Br J Cancer; 2003 Nov; 89(9):1736-42. PubMed ID: 14583778
[TBL] [Abstract][Full Text] [Related]
17. The CD4/CD8 ratio of tumor-infiltrating lymphocytes at the tumor-host interface has prognostic value in triple-negative breast cancer.
Wang K; Shen T; Siegal GP; Wei S
Hum Pathol; 2017 Nov; 69():110-117. PubMed ID: 28993275
[TBL] [Abstract][Full Text] [Related]
18. High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer.
Piersma SJ; Jordanova ES; van Poelgeest MI; Kwappenberg KM; van der Hulst JM; Drijfhout JW; Melief CJ; Kenter GG; Fleuren GJ; Offringa R; van der Burg SH
Cancer Res; 2007 Jan; 67(1):354-61. PubMed ID: 17210718
[TBL] [Abstract][Full Text] [Related]
19. B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas.
Wang X; Wang T; Xu M; Xiao L; Luo Y; Huang W; Zhang Y; Geng W
Hum Immunol; 2014 Dec; 75(12):1203-9. PubMed ID: 25446402
[TBL] [Abstract][Full Text] [Related]
20. Treatment outcomes of patients with adenocarcinoma of the uterine cervix after definitive radiotherapy and the prognostic impact of tumor-infiltrating CD8+ lymphocytes in pre-treatment biopsy specimens: a multi-institutional retrospective study.
Miyasaka Y; Yoshimoto Y; Murata K; Noda SE; Ando K; Ebara T; Okonogi N; Kaminuma T; Yamada S; Ikota H; Yokoo H; Ohno T; Nakano T
J Radiat Res; 2020 Mar; 61(2):275-284. PubMed ID: 32052042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
